中风与神经疾病杂志2025，Vol.42Issue(3)：258-261,4.DOI:10.19845/j.cnki.zfysjjbzz.2025.0052
艾加莫德治疗复发的重症抗NMDAR脑炎合并MOGAD 1例报告
Clinical effect of efgartigimod in treatment of severe anti-N-methyl-D-aspartate receptor encephalitis comorbid with myelin oligodendrocyte glycoprotein antibody-associated disorders:A case report and literature review
摘要
Abstract
This article reports the clinical features and prognosis of a patient with severe recurrent anti-N-methyl-D-aspartate receptor encephalitis comorbid with myelin oligodendrocyte glycoprotein antibody-associated disor-ders(MOGAD)who was treated with efgartigimod.Neuroimmune overlap syndrome has complex clinical manifestations,and the novel FcRn antagonist efgartigimod may be effective in patients who do not respond well to first-line treatment.关键词
抗NMDA脑炎/髓鞘少突胶质细胞糖蛋白抗体相关疾病Key words
Anti-N-methyl-D-aspartate receptor encephalitis/Myelin oligodendrocyte glycoprotein antibody-associated disorders分类
医药卫生引用本文复制引用
杜静,曹树刚,曹磊,王敏,许思,田仰华..艾加莫德治疗复发的重症抗NMDAR脑炎合并MOGAD 1例报告[J].中风与神经疾病杂志,2025,42(3):258-261,4.基金项目
安徽医科大学第二附属医院转化医学研究科研基金(2022ZHYJ08) （2022ZHYJ08）
